November 4, 2013

Helix BioPharma Corp. Announces Completion of Private Placement (PDF)

Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed a private placement with net proceeds in excess of CDN$4.6 million, after fees and expenses associated with this transaction.